Drug firm Cadila Healthcare today reported 34.58 per cent dip in consolidated net profit to Rs 281.6 crore for the third quarter ended December 31, 2016-17.
It had posted net profit of Rs 430.5 crore for the October -December period of 2015-16, Cadila said in a filing to BSE.
The company’s consolidated total income from operations also declined to Rs 2,363.8 crore for the quarter under review, as against Rs 2,408.9 crore in the year-ago period.
Cadila Healthcare stock was trading 8.81 per cent down at Rs 342.50 on BSE.
(This article has not been edited by DNA’s editorial team and is auto-generated from an agency feed.)
Source: dnaindia.com